LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Search

Moderna Inc

Slēgts

SektorsVeselības aprūpe

49.07 -1.88

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

47.88

Max

49.84

Galvenie mērījumi

By Trading Economics

Ienākumi

-517M

-1.3B

Pārdošana

-289M

389M

EPS

-3.4

Peļņas marža

-345.244

Darbinieki

4,700

EBITDA

-597M

-1.3B

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-10.59% downside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 31. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.7B

21B

Iepriekšējā atvēršanas cena

50.95

Iepriekšējā slēgšanas cena

49.07

Ziņu noskaņojums

By Acuity

67%

33%

305 / 345 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Moderna Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 18. febr. 14:18 UTC

Galvenie tirgus virzītāji

Moderna Shares Gain After New Flu Vaccine Clears Regulatory Hurdle

2026. g. 13. febr. 14:10 UTC

Peļņas

Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls -- Update

2026. g. 10. febr. 23:26 UTC

Galvenie tirgus virzītāji

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

2025. g. 2. jūn. 10:41 UTC

Galvenie tirgus virzītāji

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine

2026. g. 11. maijs 20:22 UTC

Karstas akcijas

Stocks to Watch: Moderna, Intel, Micron, Fox -- WSJ

2026. g. 11. maijs 13:47 UTC

Karstas akcijas

Stocks to Watch: Moderna, Intel, Micron, Fox -- WSJ

2026. g. 1. maijs 18:35 UTC

Peļņas

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

2026. g. 1. maijs 14:53 UTC

Peļņas

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

2026. g. 4. marts 21:50 UTC

Peļņas

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026. g. 4. marts 17:08 UTC

Peļņas

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, GitLab, Seagate, Sandisk, and More -- Barrons.com

2026. g. 4. marts 10:18 UTC

Karstas akcijas

Stocks to Watch Wednesday: CrowdStrike, Gitlab, Moderna, Strategy, Coinbase -- WSJ

2026. g. 18. febr. 15:33 UTC

Peļņas

These Stocks Are Today's Movers: Nvidia, Palantir, Moderna, Global Payments, Garmin, Caesars, Palo Alto, and More -- Barrons.com

2026. g. 13. febr. 21:20 UTC

Peļņas

Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers -- Barrons.com

2026. g. 13. febr. 19:51 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More -- Barrons.com

2026. g. 13. febr. 17:16 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More -- Barrons.com

2026. g. 13. febr. 15:01 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Rivian, Moderna, Steel Dynamics, Coinbase, DraftKings, Tri Pointe Homes, and More -- Barrons.com

2026. g. 13. febr. 14:02 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Arista, Moderna, Coinbase, DraftKings, Steel Dynamics, Rivian, Roku, Pinterest, and More -- Barrons.com

2026. g. 13. febr. 13:21 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Arista, Moderna, Coinbase, DraftKings, Steel Dynamics, Rivian, Roku, Pinterest, and More -- Barrons.com

2026. g. 13. febr. 12:19 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Arista, Moderna, Coinbase, DraftKings, Expedia, Rivian, Roku, Pinterest, and More -- Barrons.com

2026. g. 13. febr. 10:54 UTC

Peļņas

These Stocks Are Today's Movers: Applied Materials, Arista, Coinbase, DraftKings, Expedia, Rivian, Roku, Pinterest, and More -- Barrons.com

2026. g. 11. febr. 15:40 UTC

Peļņas

These Stocks Are Today's Movers: Shopify, Moderna, Robinhood, Vertiv, Unity, Zillow, Beta Tech, Lyft, Mattel, Astera, and More -- Barrons.com

2026. g. 11. febr. 15:00 UTC

Karstas akcijas

Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB -- WSJ

2026. g. 22. janv. 18:01 UTC

Peļņas

These Stocks Are Today's Movers: Intel, GE Aerospace, Moderna, Abbott, Arista Networks, Mobileye, McCormick, and More -- Barrons.com

2025. g. 6. nov. 16:16 UTC

Peļņas

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

2025. g. 6. nov. 12:29 UTC

Peļņas

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025. g. 6. nov. 12:15 UTC

Peļņas

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025. g. 1. okt. 20:20 UTC

Iegādes, apvienošanās, pārņemšana

These Stocks Moved the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More -- Barrons.com

2025. g. 10. jūn. 12:18 UTC

Peļņas

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. -- Barrons.com

2025. g. 27. maijs 17:59 UTC

Top Ziņas

Kennedy, Skipping Regulatory Steps, Limits Use of Covid-19 Shots -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Moderna Inc Prognoze

Cenas mērķis

By TipRanks

-10.59% uz leju

Prognoze 12 mēnešiem

Vidējais 44.73 USD  -10.59%

Augstākais 69 USD

Zemākais 32 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Moderna Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

15 ratings

1

Pirkt

13

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

23.7 / 27.88Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

305 / 345 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat